%0 Journal Article %T Stereotactic radiotherapy in previously treated lung cancers—what are the risks? %A Filippi, Andrea Riccardo %A Lancia, Andrea %A Trovo, Marco %J Therapeutic Radiology and Oncology %D 2019 %B 2019 %9 %! Stereotactic radiotherapy in previously treated lung cancers—what are the risks? %K %X Patients affected by intra-thoracic recurrences of primary or secondary lung malignancies after the first course of definitive radiotherapy (RT) have limited therapeutic options, and they are often treated with palliative intent. Re-irradiation with stereotactic radiotherapy (SRT) represents an appealing approach, due to the optimized dose distribution that allows for high-dose delivery with better sparing of organs at risk; however, toxicity still represents an issue, even with dose-fractionation risk-adapted approaches. This review aims to analyze clinical data and dosimetric parameters related to stereotactic re-irradiation, mainly focusing on the toxicity profile, whose risk often limits the adoption of this technique in clinical practice. %U http://tro.amegroups.com/article/view/4975 %V 3 %P